Company Profiles

driven by the PitchBook Platform

Aterovax

Description

Developer of diagnostic products for the treatment of atherosclerosis. The company develops diagnostic tests for cardiovascular risk prediction by assessing the level of patients' atherosclerosis plaque development.

2006

Founded

OOB

Status

1-10

Employees

Out of Business

Latest Deal Type

$5.76M

Total Amount Raised

Description

Developer of diagnostic products for the treatment of atherosclerosis. The company develops diagnostic tests for cardiovascular risk prediction by assessing the level of patients' atherosclerosis plaque development.

Website:

www.aterovax.com

Ownership Status

Out of business

Financing Status

Formerly VC-Backed

Primary Industry

Laboratory Services (Healthcare)

Other Industries

Medical Supplies
Diagnostic Equipment

Primary Office

Pepiniere paris Sante Cochin 29 rue du Faubourg Saint-Jacques 75014 ParisFrance
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Aterovax's full profile, request a free trial.

    Aterovax Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Aterovax Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Gerald Ulrich Ph.DChief Operative Officer
    Emmanuel Valentin Ph.DHead & Director, Research & Development
    Gerald Ulrich Ph.D Chief Operative Officer
    Emmanuel Valentin Ph.D Head & Director, Research & Development

    Aterovax Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    Antoine Ferry MDSelfBoard Member000 0000
    Eric ViaudSelfBoard Member000 0000
    Antoine Ferry MD Board Member Self
    Eric Viaud Board Member Self
    Request full access to PitchBook